Diversified Healthcare Trust (DHC) Income Statement
DHC 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsDHC revenue and net income
Where DHC's revenue goes
2025Each bar shows an amount and its share of revenue. DHC kept −18.6% of revenue as net income.
DHC profit margins
DHC growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +2.8% | +6.2% | −1.2% | +4.4% |
| Gross profit | −195.7% | — | — | — |
| Operating income | −117.1% | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
DHC quarterly EPS vs estimates
Diversified Healthcare beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 2, 2026 (estimate $0.15).
DHC income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.54B | $1.50B | $1.41B | $1.28B | $1.38B | $1.63B | $1.04B | $1.12B | $1.07B | $1.06B |
| Cost of revenue | $1.78B | $1.24B | $1.19B | $1.11B | $1.09B | $1.24B | $502.2M | $451.8M | $413.9M | $401.9M |
| Gross profit | −$245.3M | $256.4M | $225.3M | $174.5M | $291.4M | $394.9M | $538.0M | $665.4M | $660.8M | $656.1M |
| Research & development | — | — | $0 | $0 | $0 | $0 | $0 | $1 | $0 | $0 |
| Sales, general & admin | $45.5M | $26.5M | $26.1M | $26.4M | $34.1M | $30.6M | $37.0M | $85.9M | $103.7M | $46.6M |
| Total operating expenses | −$206.1M | $26.5M | $26.1M | $265.7M | $305.2M | $30.6M | $37.0M | $85.9M | $103.7M | $46.6M |
| Operating income | −$39.3M | $229.9M | $199.2M | −$91.2M | −$13.8M | $364.3M | $501.0M | $579.5M | $557.1M | $609.6M |
| Interest income | $5.8M | $8.9M | $21.7M | $15.9M | $20.6M | $18.2M | $941,000 | $667,000 | $406,000 | $430,000 |
| Interest expense | $204.5M | $235.2M | $191.8M | $209.4M | $255.8M | $201.5M | $180.1M | $179.3M | $165.0M | $167.6M |
| Income before taxes | −$284.1M | −$369.8M | −$293.1M | −$15.1M | $181.4M | −$133.1M | −$82.4M | $292.9M | $152.3M | $141.7M |
| Income taxes | $1.7M | $467,000 | $445,000 | $710,000 | $1.4M | $1.2M | $436,000 | $476,000 | $454,000 | $424,000 |
| Net income | −$285.9M | −$370.3M | −$293.6M | −$15.8M | $174.5M | −$139.5M | −$88.2M | $286.9M | $147.6M | $141.3M |
| EBITDA | $182.3M | $230.0M | $198.9M | $427.8M | $708.2M | $356.9M | $494.2M | $573.7M | $551.8M | $604.6M |
| EPS (diluted) | −$0.72 | −$1.28 | −$1.23 | $0.13 | −$1.20 | −$0.22 | $0.18 | $0.68 | $0.68 | $0.65 |
| Gross margin | −16.0% | 17.1% | 16.0% | 13.6% | 21.1% | 24.2% | 51.7% | 59.6% | 61.5% | 62.0% |
| Operating margin | −2.6% | 15.4% | 14.1% | −7.1% | −1.0% | 22.3% | 48.2% | 51.9% | 51.8% | 57.6% |
| Net margin | −18.6% | −24.8% | −20.8% | −1.2% | 12.6% | −8.5% | −8.5% | 25.7% | 13.7% | 13.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $365.4M | $366.5M | $379.6M | $388.7M | $382.7M | $386.9M | $379.6M | $373.6M | $371.4M | $370.8M | $361.5M | $356.5M |
| Cost of revenue | $406.0M | $416.4M | $431.1M | $325.4M | $312.6M | $314.4M | $315.4M | $310.0M | $305.9M | $307.7M | $304.5M | $302.1M |
| Gross profit | −$40.6M | −$49.9M | −$51.5M | $63.3M | $70.1M | $72.5M | $64.2M | $63.6M | $65.5M | $63.1M | $57.1M | $54.4M |
| Sales, general & admin | $19.3M | $14.0M | $12.5M | $12.8M | $11.2M | $9.0M | $1.2M | $13.9M | $6.3M | $7.6M | $6.0M | $7.0M |
| Total operating expenses | −$40.1M | −$45.2M | −$40.4M | $78.1M | $77.4M | $9.0M | $1.2M | $13.9M | $6.3M | $7.6M | $6.0M | $7.0M |
| Operating income | −$518,000 | −$4.7M | −$11.1M | −$14.8M | −$7.3M | $63.5M | $62.9M | $49.7M | $59.2M | $55.5M | $51.1M | $47.5M |
| Interest income | $258,000 | $233,000 | $1.5M | — | $3.0M | $2.1M | $1.7M | $2.6M | $2.4M | $2.2M | $3.0M | $3.2M |
| Interest expense | $37.0M | $37.0M | $95.0M | $49.7M | $50.9M | $57.8M | $59.5M | $59.4M | $58.7M | $57.6M | $48.9M | $47.8M |
| Income before taxes | −$36.1M | −$42.7M | −$20.7M | −$163.7M | −$90.8M | −$8.9M | −$87.5M | −$98.5M | −$97.7M | −$86.1M | −$102.5M | −$65.6M |
| Income taxes | $1.3M | $622,000 | $514,000 | $337,000 | $843,000 | $49,000 | −$38,000 | $148,000 | $170,000 | $187,000 | $66,000 | $189,000 |
| Net income | −$37.4M | −$43.3M | −$21.2M | −$164.0M | −$91.6M | −$9.0M | −$87.4M | −$98.7M | −$97.9M | −$86.3M | −$102.6M | −$65.8M |
| EBITDA | $63.4M | $57.3M | $136.3M | −$53.8M | $23.3M | $63.5M | $65.4M | $49.7M | $59.3M | $55.5M | $51.1M | $47.5M |
| EPS (diluted) | $0.16 | −$0.13 | −$0.06 | −$0.22 | −$0.20 | −$0.24 | −$0.27 | −$0.41 | −$0.32 | −$0.28 | −$0.43 | −$0.28 |
| Gross margin | −11.1% | −13.6% | −13.6% | 16.3% | 18.3% | 18.7% | 16.9% | 17.0% | 17.6% | 17.0% | 15.8% | 15.3% |
| Operating margin | −0.1% | −1.3% | −2.9% | −3.8% | −1.9% | 16.4% | 16.6% | 13.3% | 16.0% | 15.0% | 14.1% | 13.3% |
| Net margin | −10.2% | −11.8% | −5.6% | −42.2% | −23.9% | −2.3% | −23.0% | −26.4% | −26.3% | −23.3% | −28.4% | −18.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in DHC's financial statements (latest annual report filed February 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
DHC financial results
In fiscal year 2025 (ended December 31, 2025), Diversified Healthcare reported revenue of $1.5 billion, up 2.8% from the year before. It had a net loss of $285.9 million, a net profit margin of −18.6%. Diluted earnings per share came to −$0.72. Over five years revenue grew at an average rate of −1.2% a year.
See the DHC stock overview for the latest quote and news, or the DHC chart for price history and technical indicators.
DHC income statement FAQ
What is Diversified Healthcare's annual revenue?
Diversified Healthcare reported total revenue of $1.5 billion for fiscal year 2025, which ended on December 31, 2025. That was up 2.8% from $1.5 billion the previous year.
Is Diversified Healthcare profitable?
No. Diversified Healthcare reported a net loss of $285.9 million in fiscal 2025, a net profit margin of −18.6%; its operating margin was −2.6%.
What is Diversified Healthcare's gross margin?
Diversified Healthcare's gross margin was −16.0% in fiscal 2025: for every $100 of revenue, Diversified Healthcare kept $-16 after the direct cost of its products and services.
How fast is Diversified Healthcare growing?
Revenue grew −1.2% a year on average over the last five fiscal years, from $1.6 billion to $1.5 billion.
What are Diversified Healthcare's earnings per share?
Diversified Healthcare earned $-0.72 per diluted share in fiscal 2025, compared with $-1.28 a year earlier.
When will Diversified Healthcare report its next earnings?
Diversified Healthcare is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 after the market closes.
When does Diversified Healthcare's fiscal year end?
Diversified Healthcare's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 24, 2026.